Amgen Share Price (AMGN.US)

Amgen is listed on the CBOE trading with ticker code AMGN.US. It has a market capitalisation of $195.45b, with approximately 540.01m shares in issue. Over the last year, Amgen share price has been traded in a range of 121.22, hitting a high of 391.06, and a low of 269.84.

Amgen Inc. is a leading global biotechnology company headquartered in Thousand Oaks, California. Founded in 1980, Amgen specialises in developing and manufacturing innovative therapies for serious illnesses, focusing on areas such as oncology, cardiology, nephrology, and inflammation. Notable products include Neulasta, Enbrel, and Repatha. Committed to advancing science and improving patient outcomes, Amgen invests heavily in research and development to discover and deliver breakthrough medicines. The company's dedication to biotechnology and its mission to serve patients make it a prominent player in the biopharmaceutical industry, impacting healthcare worldwide.